193 related articles for article (PubMed ID: 15773293)
21. The possible role of endocrine disrupting chemicals in the aetiology of cryptorchidism and hypospadias: a population-based case-control study in rural Sicily.
Carbone P; Giordano F; Nori F; Mantovani A; Taruscio D; Lauria L; Figà-Talamanca I
Int J Androl; 2007 Feb; 30(1):3-13. PubMed ID: 16824044
[TBL] [Abstract][Full Text] [Related]
22. Maternal exposure to a brominated flame retardant and genitourinary conditions in male offspring.
Small CM; DeCaro JJ; Terrell ML; Dominguez C; Cameron LL; Wirth J; Marcus M
Environ Health Perspect; 2009 Jul; 117(7):1175-9. PubMed ID: 19654930
[TBL] [Abstract][Full Text] [Related]
23. Changes in male reproductive health and effects of endocrine disruptors in Scandinavian countries.
Toppari J; Haavisto AM; Alanen M
Cad Saude Publica; 2002; 18(2):413-20. PubMed ID: 11923882
[TBL] [Abstract][Full Text] [Related]
24. [Exposure to endocrine disruptors and male urogenital tract malformations [cryptorchidism and hypospadias]].
Fernández MF; Olmos B; Olea N
Gac Sanit; 2007; 21(6):500-14. PubMed ID: 18001666
[TBL] [Abstract][Full Text] [Related]
25. Toward the effective surveillance of hypospadias.
Dolk H; Vrijheid M; Scott JE; Addor MC; Botting B; de Vigan C; de Walle H; Garne E; Loane M; Pierini A; Garcia-Minaur S; Physick N; Tenconi R; Wiesel A; Calzolari E; Stone D
Environ Health Perspect; 2004 Mar; 112(3):398-402. PubMed ID: 14998760
[TBL] [Abstract][Full Text] [Related]
26. Cryptorchidism and endocrine disrupting chemicals.
Virtanen HE; Adamsson A
Mol Cell Endocrinol; 2012 May; 355(2):208-20. PubMed ID: 22127307
[TBL] [Abstract][Full Text] [Related]
27. 'Idiopathic' partial androgen insensitivity syndrome in 28 newborn and infant males: impact of prenatal exposure to environmental endocrine disruptor chemicals?
Gaspari L; Paris F; Philibert P; Audran F; Orsini M; Servant N; Maïmoun L; Kalfa N; Sultan C
Eur J Endocrinol; 2011 Oct; 165(4):579-87. PubMed ID: 21788424
[TBL] [Abstract][Full Text] [Related]
28. [Exposure to endocrine disrupting chemicals and children's health: problems in epidemiological studies].
Kishi R; Sata F; Saijo Y; Kurahashi N; Kato S; Nakajima S; Sasaki S
Nihon Eiseigaku Zasshi; 2006 Jan; 61(1):19-31. PubMed ID: 16506651
[TBL] [Abstract][Full Text] [Related]
29. Trends in the incidence of cryptorchidism and hypospadias, and methodological limitations of registry-based data.
Toppari J; Kaleva M; Virtanen HE
Hum Reprod Update; 2001; 7(3):282-6. PubMed ID: 11392374
[TBL] [Abstract][Full Text] [Related]
30. Genital anomalies in boys and the environment.
Main KM; Skakkebaek NE; Virtanen HE; Toppari J
Best Pract Res Clin Endocrinol Metab; 2010 Apr; 24(2):279-89. PubMed ID: 20541152
[TBL] [Abstract][Full Text] [Related]
31. Parental occupational exposure to potential endocrine disrupting chemicals and risk of hypospadias in infants.
Nassar N; Abeywardana P; Barker A; Bower C
Occup Environ Med; 2010 Sep; 67(9):585-9. PubMed ID: 19939854
[TBL] [Abstract][Full Text] [Related]
32. Risk of hypospadias in relation to maternal occupational exposure to potential endocrine disrupting chemicals.
Vrijheid M; Armstrong B; Dolk H; van Tongeren M; Botting B
Occup Environ Med; 2003 Aug; 60(8):543-50. PubMed ID: 12883014
[TBL] [Abstract][Full Text] [Related]
33. Cryptorchidism and hypospadias in sons of gardeners and farmers.
Weidner IS; Møller H; Jensen TK; Skakkebaek NE
Environ Health Perspect; 1998 Dec; 106(12):793-6. PubMed ID: 9831539
[TBL] [Abstract][Full Text] [Related]
34. Residential sources of pesticide exposure during pregnancy and the risks of hypospadias and cryptorchidism: the French ELFE birth cohort.
Cognez N; Warembourg C; Zaros C; Metten MA; Bouvier G; Garlantézec R; Charles MA; Béranger R; Chevrier C
Occup Environ Med; 2019 Sep; 76(9):672-679. PubMed ID: 31413190
[TBL] [Abstract][Full Text] [Related]
35. A novel biomarker for anti-androgenic activity in placenta reveals risks of urogenital malformations.
Arrebola JP; Molina-Molina JM; Fernández MF; Sáenz JM; Amaya E; Indiveri P; Hill EM; Scholze M; Orton F; Kortenkamp A; Olea N
Reproduction; 2015 Jun; 149(6):605-13. PubMed ID: 25784770
[TBL] [Abstract][Full Text] [Related]
36. [Recent trends in male reproductive disorders].
Iwamoto T; Nozawa S
Nihon Rinsho; 2000 Dec; 58(12):2514-20. PubMed ID: 11187747
[TBL] [Abstract][Full Text] [Related]
37. Maternal pregnancy levels of trans-nonachlor and oxychlordane and prevalence of cryptorchidism and hypospadias in boys.
Trabert B; Longnecker MP; Brock JW; Klebanoff MA; McGlynn KA
Environ Health Perspect; 2012 Mar; 120(3):478-82. PubMed ID: 21975279
[TBL] [Abstract][Full Text] [Related]
38. Endocrine disruptors and testicular function.
Lymperi S; Giwercman A
Metabolism; 2018 Sep; 86():79-90. PubMed ID: 29605435
[TBL] [Abstract][Full Text] [Related]
39. Assessing the relationship between hypospadias risk and parental occupational exposure to potential endocrine-disrupting chemicals.
Das D; Dutta HK; Borbora D; Brahma RC; Das JM
Occup Environ Med; 2023 Feb; 80(2):93-96. PubMed ID: 36572527
[TBL] [Abstract][Full Text] [Related]
40. Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring: the Generation R Study.
Snijder CA; Kortenkamp A; Steegers EA; Jaddoe VW; Hofman A; Hass U; Burdorf A
Hum Reprod; 2012 Apr; 27(4):1191-201. PubMed ID: 22301570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
